Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
Clinical trial NCT04428502 · COMPLETED
Trial details
- NCT number
- NCT04428502
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-05
- Primary completion
- 2020-08-30
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.